Hyung J. Won

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Diagnostic Accuracy of Extracellular versus Hepatobiliary Contrast-enhanced MRI in LI-RADS Nonradiation Treatment Response Algorithm Version 2024.

Diagnostic Accuracy of Extracellular versus Hepatobiliary Contrast-enhanced MRI in LI-RADS Nonradiation Treatment Response Algorithm Version 2024.

Journal: Radiology

Published: June 09, 2026

Prognostic Implications of CT- and MRI-Based LI-RADS Category M Features in Intrahepatic Cholangiocarcinoma: An Intraindividual Comparison.

Prognostic Implications of CT- and MRI-Based LI-RADS Category M Features in Intrahepatic Cholangiocarcinoma: An Intraindividual Comparison.

Journal: Korean journal of radiology

Published: April 21, 2026

Gadoxetate-enhanced MRI Transitional Phase Parenchymal Signal: Effect on Washout and LI-RADS Diagnostic Performance for Hepatocellular Carcinoma.

Gadoxetate-enhanced MRI Transitional Phase Parenchymal Signal: Effect on Washout and LI-RADS Diagnostic Performance for Hepatocellular Carcinoma.

Journal: Radiology

Published: March 31, 2026

Diagnostic Value of Precontrast Low Attenuation as a LI-RADS CT Ancillary Feature for Hepatocellular Carcinoma.

Diagnostic Value of Precontrast Low Attenuation as a LI-RADS CT Ancillary Feature for Hepatocellular Carcinoma.

Journal: Radiology

Published: November 25, 2025

Percutaneous Radiofrequency Ablation of Perivascular versus Nonperivascular Hepatocellular Carcinomas ≤3 cm: Local Tumor Progression and Survival in an Inverse Probability of Treatment Weighting Analysis.

Percutaneous Radiofrequency Ablation of Perivascular versus Nonperivascular Hepatocellular Carcinomas ≤3 cm: Local Tumor Progression and Survival in an Inverse Probability of Treatment Weighting Analysis.

Journal: Journal of vascular and interventional radiology : JVIR

Published: August 21, 2025

Comparison of MRI and prognostic features of intrahepatic cholangiocarcinoma between patients with and without hepatitis B virus infection.

Comparison of MRI and prognostic features of intrahepatic cholangiocarcinoma between patients with and without hepatitis B virus infection.

Journal: Abdominal radiology (New York)

Published: April 09, 2025

Value of enhancing capsule for diagnosing hepatocellular carcinoma on MRI: implications for simplifying LI-RADS.

Value of enhancing capsule for diagnosing hepatocellular carcinoma on MRI: implications for simplifying LI-RADS.

Journal: European radiology

Published: April 01, 2025

LI-RADS Ultrasound Surveillance Version 2024: Comparison With Version 2017 for Hepatocellular Carcinoma Detection and Risk Factors for Visualization Score C.

LI-RADS Ultrasound Surveillance Version 2024: Comparison With Version 2017 for Hepatocellular Carcinoma Detection and Risk Factors for Visualization Score C.

Journal: AJR. American journal of roentgenology

Published: January 22, 2025

CT- and MRI-based Factors Associated with Rapid Growth in Early-Stage Hepatocellular Carcinoma.

CT- and MRI-based Factors Associated with Rapid Growth in Early-Stage Hepatocellular Carcinoma.

Journal: Radiology

Published: December 24, 2024

Preoperative scoring system for predicting microvascular invasion in intrahepatic cholangiocarcinoma using gadoxetate-enhanced MRI.

Preoperative scoring system for predicting microvascular invasion in intrahepatic cholangiocarcinoma using gadoxetate-enhanced MRI.

Journal: European radiology

Published: December 14, 2024

Effect of combining serum alpha-fetoprotein with LI-RADS v2018 on gadoxetate-enhanced MRI in the diagnosis and prognostication of hepatocellular carcinoma.

Effect of combining serum alpha-fetoprotein with LI-RADS v2018 on gadoxetate-enhanced MRI in the diagnosis and prognostication of hepatocellular carcinoma.

Journal: European radiology

Published: September 06, 2024

Chemoembolization versus radiofrequency ablation for single small (≤ 3 cm) hepatocellular carcinoma: a propensity score matching analysis.

Chemoembolization versus radiofrequency ablation for single small (≤ 3 cm) hepatocellular carcinoma: a propensity score matching analysis.

Journal: European radiology

Published: September 09, 2023

Showing 1-12 of 66

Last Updated: 09/26/2026